The cancer stem cell hypothesis: Failures and pitfalls

Neurosurgery

Volumn 68, Issue 2, 2011, Pages 531-545

  Rahman, Maryam ^a   Deleyrolle, Loic ^a   Vedam Mai, Vinata ^a   Azari, Hassan ^a   Abd El Barr, Muhammad ^a,b   Reynolds, Brent A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cancer stem cells; Glioma; Tumor initiating cells

Indexed keywords

BETA CATENIN; BMI1 PROTEIN; CD133 ANTIGEN; CD15 ANTIGEN; CD24 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CELL MARKER; ESA PROTEIN; HERMES ANTIGEN; IMATINIB; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; BREAST CANCER; CANCER GROWTH; CANCER RESISTANCE; CANCER STEM CELL; CANCER STEM CELL HYPOTHESIS; CANCER TRANSPLANTATION; CARCINOGENESIS; CARCINOGENICITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CELL TRANSFORMATION; CHRONIC MYELOID LEUKEMIA; GLIOBLASTOMA; HEMATOPOIETIC STEM CELL; HUMAN; HYPOTHESIS; LYMPHOMA; NEURAL STEM CELL; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SOMATIC CELL; SOMATIC NEURAL STEM CELL; STEM CELL; TARGET CELL; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR INITIATING CELL; XENOTRANSPLANTATION;

ANIMALS; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS;

EID: 79951674942     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e3181ff9eb5     Document Type: Review

References (158)

1. Ignatius MS, Langenau DM. Zebrafish as a model for cancer self-renewal. Zebrafish. 2009;6(4):377-387.
2. Heppner GH, Miller FR. The cellular basis of tumor progression. Int Rev Cytol. 1998;177:1-56. (Pubitemid 128716720)
3. Tysnes BB, Bjerkvig R. Cancer initiation and progression: Involvement of stem cells and the microenvironment. Biochim Biophys Acta. 2007;1775(2):283-297. (Pubitemid 46901154)
4. Nowell PC. The clonal evolution of tumor cell populations. Science. 1976;194(4260):23-28.
5. Merlo LM, Pepper JW, Reid BJ, Maley CC. Cancer as an evolutionary and ecological process. Nat Rev Cancer. 2006;6(12):924-935. (Pubitemid 44862677)
6. Nicolson GL, Rosenberg NL. Diversification and progression of malignant tumors. Bioessays. 1987;6(5):204-208.
7. Campbell LL, Polyak K. Breast tumor heterogeneity: Cancer stem cells or clonal evolution? Cell Cycle. 2007;6(19):2332-2338. (Pubitemid 350058682)
8. Wolman SR. Cytogenetic heterogeneity: Its role in tumor evolution. Cancer Genet Cytogenet. 1986;19(1-2):129-140. (Pubitemid 16149780)
9. National Cancer Institute. Cancer mortality maps and graphs web site. http:// cancer.gov/atlasp. Accessed January 2010.
10. Ichim CV, Wells RA. First among equals: The cancer cell hierarchy. Leuk Lymphoma. 2006;47(10):2017-2027. (Pubitemid 44650076)
11. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414(6859):105-111. (Pubitemid 33041634)
12. Wicha MS, Liu S, Dontu G. Cancer stem cells: An old idea-A paradigm shift. Cancer Res. 2006;66(4):1883-1890.
13. Pardal R, Clarke MF,Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer. 2003;3(12):895-902. (Pubitemid 37500174)
14. Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J, Terzis AJ. Opinion: The origin of the cancer stem cell: Current controversies and new insights. Nat Rev Cancer. 2005;5(11):899-904. (Pubitemid 41746034)
15. Polyak K, Hahn WC. Roots and stems: stem cells in cancer. Nat Med. 2006; 12(3):296-300. (Pubitemid 43355075)
16. Potten CS, Loeffler M. Stem cells: Attributes, cycles, spirals, pitfalls and uncertainties: lessons for and from the crypt. Development. 1990;110(4):1001-1020. (Pubitemid 120009472)
17. Virchow R. Editorial.Virchows Arch Pathol Anat Physiol Klin Med. 1855;3:23.
18. Cohnheim J. Ueber entzundung und eiterung. Path Anat Physiol Klin Med. 1867;40:1-79.
19. Park CH, Bergsagel DE, McCulloch EA. Mouse myeloma tumor stem cells: A primary cell culture assay. J Natl Cancer Inst. 1971;46(2):411-422.
20. Brunschwig A, Southam CM, Levin AG. Host resistance to cancer: Clinical experiments by homotransplants, autotransplants and admixture of autologous leucocytes. Ann Surg. 1965;162(3):416-425.
21. Bruce WR, Van Der Gaag H. A quantitative assay for the number of murine lymphoma cells capable of proliferation in vivo. Nature. 1963;199:79-80.
22. Huntly BJ, Gilliland DG. Cancer biology: summing up cancer stem cells. Nature. 2005;435(7046):1169-1170. (Pubitemid 40943069)
23. Huntly BJ, Gilliland DG. Leukaemia stem cells and the evolution of cancer-stemcell research. Nat Rev Cancer. 2005;5(4):311-321. (Pubitemid 40488636)
24. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. NatMed. 1997;3(7):730-737. (Pubitemid 27298715)
25. Fialkow PJ, Jacobson RJ, Papayannopoulou T. Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med. 1977;63(1):125-130. (Pubitemid 8146659)
26. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100(7):3983-3988. (Pubitemid 36418143)
27. Eramo A, Lotti F, Sette G, et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2008;15(3):504-514. (Pubitemid 351267301)
28. Collins AT, Berry PA, Hyde C, Stower MJ,Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005;65(23):10946-10951. (Pubitemid 41713363)
29. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445(7123):106-110. (Pubitemid 46067310)
30. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells. Nature. 2007;445(7123):111- 115. (Pubitemid 46067311)
31. Chiba T, Zheng YW, Kita K, et al. Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation. Gastroenterology. 2007;133(3): 937-950. (Pubitemid 47374130)
32. Suetsugu A, Nagaki M, Aoki H, Motohashi T, Kunisada T, Moriwaki H. Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/ progenitor cells. Biochem Biophys Res Commun. 2006;351(4):820-824. (Pubitemid 44715858)
33. Hermann PC, Huber SL, Herrler T, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 2007;1(3):313-323. (Pubitemid 47355323)
34. Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells. Cancer Res. 2007;67(3):1030-1037.
35. Galli R, Binda E, Orfanelli U, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004;64(19): 7011-7021. (Pubitemid 39331011)
36. Hemmati HD, Nakano I, Lazareff JA, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A. 2003;100(25):15178-15183. (Pubitemid 37518036)
37. Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia. 2002;39(3):193-206.
38. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature. 2004;432(7015):396-401. (Pubitemid 39551674)
39. Deininger M, Buchdunger E, Druker BJ. The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood. 2005;105(7):2640-2653. (Pubitemid 40446252)
40. Kantarjian H, Talpaz M, O'Brien S, et al. Survival benefit with imatinib mesylate therapy in patients with accelerated-phase chronic myelogenous leukemia: Comparison with historic experience. Cancer. 2005;103(10):2099-2108. (Pubitemid 40605118)
41. Blagosklonny MV. Why therapeutic response may not prolong the life of a cancer patient: selection for oncogenic resistance. Cell Cycle. 2005;4(12):1693-1698. (Pubitemid 41827304)
42. Till JE, McCulloch EA. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res. 1961;14:213-222.
43. Wu AM, Siminovitch L, Till JE, McCulloch EA. Evidence for a relationship between mouse hemopoietic stem cells and cells forming colonies in culture. Proc Natl Acad Sci U S A. 1968;59(4):1209-1215.
44. Bradley TR, Metcalf D. The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci. 1966;44(3):287-299.
45. Bradley TR, Metcalf D, Robinson W. Stimulation by leukaemic sera of colony formation in solid agar cultures by proliferation of mouse bone marrow cells. Nature. 1967;213(5079):926-927.
46. Pluznik DH, Sachs L. The cloning of normal "mast" cells in tissue culture. J Cell Physiol. 1965;66(3):319-324.
47. Cheng T, Rodrigues N, Dombkowski D, Stier S, Scadden DT. Stem cell repopulation efficiency but not pool size is governed by p27(kip1). Nat Med. 2000;6(11):1235-1240.
48. Wang JC, Dick JE. Cancer stem cells: lessons from leukemia. Trends Cell Biol. 2005;15(9):494-501. (Pubitemid 41253469)
49. Jordan CT, Guzman ML. Mechanisms controlling pathogenesis and survival of leukemic stem cells. Oncogene. 2004;23(43):7178-7187. (Pubitemid 39382152)
50. Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med. 2006; 355(12):1253-1261. (Pubitemid 44427449)
51. Blagosklonny MV. Target for cancer therapy: proliferating cells or stem cells. Leukemia. 2006;20(3):385-391. (Pubitemid 43291733)
52. Hamilton A. The division of the differentiated cells in the central nervous system of the white rate. J Comp Neurol. 1901;11:297-320.
53. Kershman J. The medulloblast and the medulloblastoma. Arch Neurol Psychiatry. 1938;40:937-967.
54. Bryans WA. Mitotic activity in the brain of the adult white rat. Anat Rec. 1959;133:65-71.
55. Altman J. Proliferation and migration of undifferentiated precursor cells in the rat during postnatal gliogenesis. Exp Neurol. 1966;16(3):263-278.
56. Altman J, Das GD. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol. 1965;124(3):319-335.
57. Dacey ML, Wallace RB. Postnatal neurogenesis in the feline cerebellum: A structural-functional investigation. Acta Neurobiol Exp (Wars). 1974;34(2): 253-263.
58. Kaplan MS, Hinds JW. Neurogenesis in the adult rat: Electron microscopic analysis of light radioautographs. Science. 1977;197(4308):1092-1094. (Pubitemid 8170019)
59. Messier B, Leblond CP, Smart I. Presence of DNA synthesis and mitosis in the brain of young adult mice. Exp Cell Res. 1958;14(1):224-226.
60. Paton JA, Nottebohm FN. Neurons generated in the adult brain are recruited into functional circuits. Science. 1984;225(4666):1046-1048. (Pubitemid 14066321)
61. Goldman SA, Nottebohm F. Neuronal production, migration, and differentiation in a vocal control nucleus of the adult female canary brain. Proc Natl Acad Sci U S A. 1983;80(8):2390-2394. (Pubitemid 13097195)
62. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science. 1992;255(5052):1707-1710.
63. Foroni C, Galli R, Cipelletti B, et al. Resilience to transformation and inherent genetic and functional stability of adult neural stem cells ex vivo. Cancer Res. 2007;67(8):3725-3733. (Pubitemid 46762158)
64. Louis SA, Rietze RL, Deleyrolle L, et al. Enumeration of neural stem and progenitor cells in the neural colony-forming cell assay. Stem Cells. 2008;26(4): 988-996.
65. Reynolds BA, Rietze RL. Neural stem cells and neurospheres: re-evaluating the relationship. Nat Methods. 2005;2(5):333-336. (Pubitemid 41130977)
66. Reynolds BA, Vescovi AL. Brain cancer stem cells: Think twice before going flat. Cell Stem Cell. 2009;5(5):466-467; author reply 468-469.
67. Gritti A, Frölichsthal-Schoeller P, Galli R, et al. Epidermal and fibroblast growth factors behave as mitogenic regulators for a single multipotent stem cell-like population from the subventricular region of the adult mouse forebrain. J Neurosci. 1999;19(9):3287-3297. (Pubitemid 29203108)
68. Weiss S, Dunne C, Hewson J, et al. Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J Neurosci. 1996;16(23):7599-7609. (Pubitemid 26389699)
69. Cameron HA, Woolley CS,McEwen BS, Gould E. Differentiation of newly born neurons and glia in the dentate gyrus of the adult rat. Neuroscience. 1993;56(2): 337-344. (Pubitemid 23274753)
70. Sun Y, Pollard S, Conti L, et al. Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture. Mol Cell Neurosci. 2008; 38(2):245-258.
71. McCulloch EA, Buick RN, Lan S, Till JE. Differentiation in human myeloblastic leukemia studied in cell culture. Am J Pathol. 1977;89(2):449-457.
72. Krivtsov AV, Twomey D, Feng Z, et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature. 2006;442(7104):818-822. (Pubitemid 44258912)
73. Castor A, Nilsson L, Astrand-Grundstrom I, et al. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nat Med. 2005;11(6):630-637. (Pubitemid 40868303)
74. Cozzio A, Passegue E, Ayton PM, Karsunky H, Cleary ML, Weissman IL. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev. 2003;17(24):3029-3035. (Pubitemid 38040767)
75. Huntly BJ, Shigematsu H, Deguchi K, et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell. 2004;6(6):587-596. (Pubitemid 40017702)
76. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nat Rev Cancer. 2008;8(10):755-768.
77. Vermeulen L, Sprick M, Kemper K, Stassi G, Medema J. Cancer stem cells: old concepts, new insights. Cell Death Differ. 2008;15(6):947-958. (Pubitemid 351712600)
78. Izaguirre CA, Curtis J, Messner H, McCulloch EA. A colony assay for blast cell progenitors in non-B non-T (common) acute lymphoblastic leukemia. Blood. 1981;57(5):823-829. (Pubitemid 11096470)
79. Linder D, Gartler SM. Glucose-6-phosphate dehydrogenase mosaicism: utilization as a cell marker in the study of leiomyomas. Science. 1965;150(692): 67-69.
80. Fialkow PJ, Gartler SM, Yoshida A. Clonal origin of chronic myelocytic leukemia in man. Proc Natl Acad Sci U S A. 1967;58(4):1468-1471.
81. Fialkow PJ, Faguet GB, Jacobson RJ, Vaidya K, Murphy S. Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood. 1981;58(5):916-919. (Pubitemid 12227928)
82. Fialkow PJ, Singer JW, Adamson JW, et al. Acute nonlymphocytic leukemia: heterogeneity of stem cell origin. Blood. 1981;57(6):1068-1073. (Pubitemid 11050810)
83. Buick RN, Chang LJ, Messner HA, Curtis JE, McCulloch EA. Self-renewal capacity of leukemic blast progenitor cells. Cancer Res. 1981;41(11)(pt 2): 4849-4852. (Pubitemid 12238103)
84. Douer D, Levin AM, Sparkes RS, et al. Chronic myelocytic leukaemia: A pluripotent haemopoietic cell is involved in the malignant clone. Br J Haematol. 1981;49(4):615-619. (Pubitemid 12193769)
85. Hamburger AW, Salmon SE. Primary bioassay of human tumor stem cells. Science. 1977;197(4302):461-463.
86. Mattox DE, Von Hoff DD. Culture of human head and neck cancer stem cells using soft agar. Arch Otolaryngol. 1980;106(11):672-674. (Pubitemid 10029303)
87. Mattox DE, Von Hoff DD. In vitro stem cell assay in head and neck squamous carcinoma. Am J Surg. 1980;140(4):527-530. (Pubitemid 10005988)
88. Vescovi AL, Galli R, Reynolds BA. Brain tumour stem cells. Nat Rev Cancer. 2006;6(6):425-436.
89. Alcantara Llaguno S, Chen J, Kwon CH, et al. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell. 2009;15(1):45-56.
90. Shipitsin M, Polyak K. The cancer stem cell hypothesis: In search of definitions, markers, and relevance. Lab Invest. 2008;88(5):459-463. (Pubitemid 351581449)
91. Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994;367(6464): 645-648. (Pubitemid 24067706)
92. Shackleton M, Vaillant F, Simpson KJ, et al. Generation of a functional mammary gland from a single stem cell. Nature. 2006;439(7072):84-88. (Pubitemid 43053633)
93. O'brien C, Pollett A, Gallinger S, Dick J. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445(7123): 106-110. (Pubitemid 46067310)
94. Ricci-Vitiani L, Lombardi D, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells. Nature. 2007;445(7123):111- 115. (Pubitemid 46067311)
95. Park SY, Lee HE, Li H, Shipitsin M, Gelman R, Polyak K. Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer. Clin Cancer Res. 2010;16(3):876-887.
96. Laks DR, Masterman-Smith M, Visnyei K, et al. Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cells. 2009;27(4):980-987.
97. Piccirillo SG, Reynolds BA, Zanetti N, et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature. 2006;444(7120):761-765. (Pubitemid 44949605)
98. Pollard SM, Yoshikawa K, Clarke I, et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell. 2009;4(6):568-580.
99. Uchida N, Buck DW, He D, et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A. 2000;97(26):14720-14725. (Pubitemid 32016642)
100. Pallini R, Ricci-Vitiani L, Banna GL, et al. Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin Cancer Res. 2008; 14(24):8205-8212.
101. Son MJ,Woolard K, Nam DH, Lee J, Fine HA. SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell. 2009;4(5):440-452.
102. Gilbertson RJ, Rich JN. Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer. 2007;7(10):733-736. (Pubitemid 47463683)
103. Folkins C, Shaked Y, Man S, et al. Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1. Cancer Res. 2009;69(18):7243-7251.
104. Bao S, Wu Q, Sathornsumetee S, et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res. 2006;66(16): 7843-7848. (Pubitemid 44299144)
105. Lee J, Kotliarova S, Kotliarov Y, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell. 2006;9(5):391-403. (Pubitemid 43668737)
106. Lee J, Son MJ, Woolard K, et al. Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell. 2008;13(1):69-80. (Pubitemid 350309742)
107. Lagasse E. Cancer stem cells with genetic instability: The best vehicle with the best engine for cancer. Gene Ther. 2008;15(2):136-142.
108. Barnes DJ, Melo JV. Primitive, quiescent and difficult to kill: The role of nonproliferating stem cells in chronic myeloid leukemia. Cell Cycle. 2006;5(24):2862-2866. (Pubitemid 44953936)
109. Guan Y, Gerhard B, Hogge DE. Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML). Blood. 2003;101(8):3142-3149. (Pubitemid 36858008)
110. Guzman ML, Swiderski CF, Howard DS, et al. Preferential induction of apoptosis for primary human leukemic stem cells. Proc Natl Acad Sci U S A. 2002;99(25):16220-16225. (Pubitemid 35462776)
111. Katayama R, Koike S, Sato S, Sugimoto Y, Tsuruo T, Fujita N. Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/BCRP-mediated drug export. Cancer Sci. 2009; 100(11):2060-2068.
112. Raaijmakers MH, de Grouw EP, Heuver LH, et al. Breast cancer resistance protein in drug resistance of primitive CD34+38- cells in acute myeloid leukemia. Clin Cancer Res. 2005;11(6):2436-2444. (Pubitemid 40490205)
113. Hirschmann-Jax C, Foster AE, Wulf GG, et al. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A. 2004;101(39):14228-14233. (Pubitemid 39305058)
114. Zhou S, Schuetz JD, Bunting KD, et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med. 2001;7(9):1028-1034. (Pubitemid 32937383)
115. Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer. 2005;5(4):275-284. (Pubitemid 40488633)
116. Bao S,Wu Q,McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444(7120): 756-760. (Pubitemid 44949604)
117. Lomonaco SL, Finniss S, Xiang C, et al. The induction of autophagy by gammaradiation contributes to the radioresistance of glioma stem cells. Int J Cancer. 2009;125(3):717-722.
118. Fu J, Liu ZG, Liu XM, et al. Glioblastoma stem cells resistant to temozolomideinduced autophagy. Chin Med J. 2009;122(11):1255-1259.
119. Meng X, Li M, Wang X, Wang Y, Ma D. Both CD133+ and CD133- subpopulations of A549 and H446 cells contain cancer-initiating cells. Cancer Sci. 2009;100(6):1040-1046.
120. Jones RJ, Matsui WH, Smith BD. Cancer stem cells: Are we missing the target? J Natl Cancer Inst. 2004;96(8):583-585. (Pubitemid 38584981)
121. Lewis MT. Faith, heresy and the cancer stem cell hypothesis. Future Oncol. 2008;4(5):585-589.
122. Masters JR, Koberle B. Curing metastatic cancer: lessons from testicular germ-cell tumours. Nat Rev Cancer. 2003;3(7):517-525. (Pubitemid 37328839)
123. Villano JL, Seery TE, Bressler LR. Temozolomide in malignant gliomas: Current use and future targets. Cancer Chemother Pharmacol. 2009;64(4):647-655.
124. Jamieson CH, Ailles LE, Dylla SJ, et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med. 2004;351(7): 657-667. (Pubitemid 39063268)
125. Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133(4):704-715. (Pubitemid 351636299)
126. Akala OO, Park IK, Qian D, Pihalja M, Becker MW, Clarke MF. Long-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors. Nature. 2008;453(7192):228-232. (Pubitemid 351667977)
127. Al-Hajj M, Becker MW, Wicha M, Weissman I, Clarke MF. Therapeutic implications of cancer stem cells. Curr Opin Genet Dev. 2004;14(1):43-47. (Pubitemid 38167476)
128. Shipitsin M, Campbell LL, Argani P, et al. Molecular definition of breast tumor heterogeneity. Cancer Cell. 2007;11(3):259-273. (Pubitemid 46349843)
129. Rapp UR, Ceteci F, Schreck R. Oncogene-induced plasticity and cancer stem cells. Cell Cycle. 2008;7(1):45-51.
130. Kim JB, Zaehres H, Wu G, et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature. 2008; 454(7204):646-650.
131. Zheng X, Shen G, Yang X, Liu W. Most C6 cells are cancer stem cells: Evidence from clonal and population analyses. Cancer Res. 2007;67(8):3691-3697. (Pubitemid 46762154)
132. Kelly PN, Dakic A, Adams JM, Nutt SL, Strasser A. Tumor growth need not be driven by rare cancer stem cells. Science. 2007;317(5836):337. (Pubitemid 47106366)
133. Vescovi A, Galli R, Reynolds B. Brain tumour stem cells. Nat Rev Cancer. 2006;6(6):425-436.
134. Brock A, Chang H, Huang S. Non-genetic heterogeneity: A mutationindependent driving force for the somatic evolution of tumours. Nat Rev Genet. 2009;10(5):336-342.
135. Tamase A, Muraguchi T, Naka K, et al. Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin. Proc Natl Acad Sci U S A. 2009;106(40):17163-17168.
136. Bruggeman SW, Hulsman D, Tanger E, et al. Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma. Cancer Cell. 2007;12(4):328-341. (Pubitemid 47539307)
137. McBride SM. Natural selection's challenge to the cancer stem cell hypothesis. Med Hypotheses. 2008;71(3):471-472.
138. Beier D, Hau P, Proescholdt M, et al. CD133(+) and CD133(-) glioblastomaderived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 2007;67(9):4010-4015. (Pubitemid 46815044)
139. Clement V, Dutoit V, Marino D, Dietrich PY, Radovanovic I. Limits of CD133 as a marker of glioma self-renewing cells. Int J Cancer. 2009;125(1): 244-248.
140. Nishide K, Nakatani Y, Kiyonari H, Kondo T. Glioblastoma formation from cell population depleted of Prominin1-expressing cells. PLoS ONE. 2009;4(8):e6869.
141. Bao S, Wu Q, Mclendon R, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444(7120): 756-760. (Pubitemid 44949604)
142. Shackleton M, Quintana E, Fearon ER, Morrison JS. Heterogeneity in cancer: Cancer stem cells versus clonal evolution. Cell. 2009;138(5):822-829.
143. Dick JE. Human stem cell assays in immune-deficient mice. Curr Opin Hematol. 1996;3(6):405-409. (Pubitemid 26408686)
144. Arai KI, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T. Cytokines: Coordinators of immune and inflammatory responses. Annu Rev Biochem. 1990;59: 783-836.
145. Adams JM, Strasser A. Is tumor growth sustained by rare cancer stem cells or dominant clones? Cancer Res. 2008;68(11):4018-4021.
146. Quintana E, Shackleton M, Sabel M, Fullen D, Johnson T, Morrison S. Efficient tumour formation by single human melanoma cells. Nature. 2008;456(7222): 593-598.
147. Kern SE, Shibata D. The fuzzy math of solid tumor stem cells: A perspective. Cancer Res. 2007;67(19):8985-8988. (Pubitemid 47535878)
148. Bruno S, Bussolati B, Grange C, et al. CD133+ renal progenitor cells contribute to tumor angiogenesis. Am J Pathol. 2006;169(6):2223-2235. (Pubitemid 351181980)
149. Zaidi HA, Kosztowski T, DiMeco F, Quinones-Hinojosa A. Origins and clinical implications of the brain tumor stem cell hypothesis. J Neurooncol. 2009;93(1): 49-60.
150. Lu X, Kang Y. Cell fusion as a hidden force in tumor progression. Cancer Res. 2009;69(22):8536-8539.
151. Ikushima H, Todo T, Ino Y, Takahashi M, Miyazawa K,Miyazono K. Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell. 2009;5(5):504-514.
152. Naka K, Hoshii T, Muraguchi T, et al. TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature. 2010; 463(7281):676-680.
153. Wang J, Sakariassen PO, Tsinkalovsky O, et al. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer. 2008;122(4):761-768.
154. Griguer CE, Oliva CR, Gobin E, et al. CD133 is a marker of bioenergetic stress in human glioma. PLoS ONE. 2008;3(11):e3655.
155. Wong DJ, Segal E, Chang HY. Stemness, cancer and cancer stem cells. Cell Cycle. 2008;7(23):3622-3624.
156. Zhou BB, Zhang H, Damelin M, Geles KG, Grindley JC, Dirks PB. Tumourinitiating cells: Challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov. 2009;8(10):806-823.
157. Jordan CT. Cancer stem cells: Controversial or just misunderstood? Cell Stem Cell. 2009;4(3):203-205.
158. Read TA, Fogarty MP, Markant SL, et al. Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma. Cancer Cell. 2009;15(2):135-147.